PROOFWAKE BIO

THREE REAL EXAMPLES · FREE TO READ

Is this paused drug worth a closer look?

Read three first looks. Each separates what the trial says, why the company says work stopped, who might control the rights, and the next question. These are sample business screens, not promises that any drug is available.

FOR BIOTECH LICENSING & PORTFOLIO TEAMS

One drug. One brief. $750.

Before you pay for a bigger review, get a human-reviewed first look at one paused clinical-stage drug. We check the public trial record and the company’s disclosures, then hand you a short brief with links and one clear next step. A 20-minute walkthrough is included.

  1. Email a public drug name, a public link, and the one question holding up your decision.
  2. We agree on fit, the delivery date and payment terms before you commit. No card or payment on this site.
  3. You get the brief and walkthrough. If the records don’t answer a question, the brief says so.

Public sources only. No private data searches, calls to asset owners, ownership certification, or full diligence. Please don’t send confidential files or patient details.

Ask about the $750 pilot

Find a free trial record · See how we check sources